March 25 (Reuters) - Kane Biotech Inc KNE.V :
* KANE BIOTECH ANNOUNCES FOURTH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS
* KANE BIOTECH INC - QTRLY LOSS PER SHARE (POST CONSOLIDATION) $0.008
March 25 (Reuters) - Kane Biotech Inc KNE.V :
* KANE BIOTECH ANNOUNCES FOURTH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS
* KANE BIOTECH INC - QTRLY LOSS PER SHARE (POST CONSOLIDATION) $0.008